Comparison of treatment satisfaction after switching from Semaglutide to Dulaglutide in patients with type 2 diabetes:a pilot study - Comparison of treatment satisfaction after switching from Semaglutide to Dulaglutide in patients with type 2 diabetes:a pilot study

Yokosuka Kyosai Hospital0 个研究点目标入组 15 人开始时间: 2022年3月23日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1) Patients with severe liver damage (up to 3 times normal upper limit of AST and ALT within 28 days before registration) (2) Patients with severe congestive heart failure and acute heart failure (3) Patients taking steroids (4) Patients with a history of diabetic ketoacidosis or diabetic coma during the past 6 months (5) Cancer patients currently undergoing treatment (6) Patients with severe infections, before and after surgery, with severe trauma (7) Patients who are contraindicated or allergic to the test drug (8) Pregnant, possibly pregnant, or wishing to become pregnant during the treatment period and lactating patients (9) Patients who participated in clinical trials or clinical trials of drugs or medical devices at the same time as this study or within 30 days before enrollment in this study (10) Other patients who are judged to be unsuitable as subjects by the judgment of a doctor

发起方

Yokosuka Kyosai Hospital